Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 835 Views
-
Last post by NHE
-
- 0 Replies
- 1119 Views
-
Last post by NHE
-
- 0 Replies
- 2444 Views
-
Last post by frodo
-
- 1 Replies
- 1115 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1653 Views
-
Last post by NHE
-
- 0 Replies
- 1408 Views
-
Last post by frodo
-
- 0 Replies
- 2185 Views
-
Last post by vesta
-
- 1 Replies
- 1143 Views
-
Last post by Petr75
-
- 0 Replies
- 122 Views
-
Last post by NHE